Market Research Logo

Conference Documentation: Peptides

The peptides market is worth $14.1Bn and is growing at an average CAGR of 8.7%. The market is forcasted to grow to $25.5Bn at the end of 2018. The market will grow due to the explosion of non communicable diseases such as metabolic and cardiovascular diseases that that have become endemic in our society.

Peptide technology has been growing at an impressive rate with enhancements in synthesis mechanisms such as solid and liquid phase synthesis. There has also been an impressive growth in the cancer peptide market with a CAGR of 9.4%. Currently the peptide market makes up only 1.55% of the overall market, but this is expected to change thanks to new technologies and the increased number of peptides in the pipeline with 120 in the clinical trial phase and 600 in the preclinical stage.

SMi proudly present their 2nd Annual conference on Peptides taking place on 8th & 9th July 2015 in London. The conference sets the stage for attendees to gain valuable insight into innovative topics such as Cyclic Peptides: R&D platforms, manufacture and stability, Oral Delivery of peptides, Cell permeable peptide therapeutics for cancer treatments and Development of Peptides for the Clinic. Along with this, the programme will provide insight into Formulating Solutions for Delivery and round table discussions on case studies demonstrating the translation of R&D peptides to the clinic.


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
9:10
Past, present and future of Peptide Platforms: Challenges and Opportunities
Dan Teufel, Head of Chemsitry, Bicycle Therapeutics Limited
9:50
Peptide-nanoconjugates: applications in biomedicine
Rosario Sanchez-Martin, Group Leader of NANOCHEMBIO research team , GENYO
10:30
Morning Coffee
11:00
Libraries of DNA encoded peptidic macrocycles for drug discovery
Stephen Hale, Senior Vice President, Biological Sciences, Ensemble Therapeutics
11:40
Peptide aggregation: Mechanism, challenges on cycle life development and analytical tools
Anna-Karin Lundback, Scientist I, MedImmune
12:20
Networking Lunch
13:30
Characterisation of novel peptide toxins for clinical and research use
Mande Holford, Assistant Professor, Hunter College/ American Museum of Natural History
14:10
Peptide Nucleic Acids as encoding and diagnostic tools
Juan J Diaz-Mochon, Ramon y Cajal Fellow , GENYO
14:50
Afternoon Tea
15:20
ROUND TABLE DISCUSSION:Translating peptide R&D to the clinic
Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
16:00
Genetic selection of cyclic peptide inhibitors of protein-protein interactions
Ali Tavassoli, Reader in Chemical Biology, University Of Southampton
16:40
Using structural biology in the design, production and study of cancer targeting peptides
Mark Howard, Reader in Biological NMR Spectroscopy, University Of Kent
17:20
Chairman’s Closing Remarks and Close of Day One
Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Alexandra Matzke-Ogi, CSO, Amcure
9:10
A novel class of peptide coagulant for surgical bleeding
Renata Zbozien, Research Manager, Haemostatix Ltd
9:50
Delivery of peptides via the oral route
Roger New, Co-founder & CSO, Proxima Concepts Ltd
10:30
Morning Coffee
11:00
Biological insights into therapeutic peptide modifications
Chiara Valenzano, Principal Scientist, UCB Celltech
11:40
Metallohelix peptidomimetics – a new area of chemical space
Peter Scott, Professor of Chemistry, University of Warwick
12:20
Networking Lunch
13:30
Antimicrobial peptides and gene-delivery peptides
James Mason , Senior Lecturer, Kings College London
14:10
Development of a first-in-class drug candidate for the treatment of metastatic cancer
Alexandra Matzke-Ogi, CSO, Amcure
14:50
Afternoon Tea
15:20
Drugging the Undruggables - Cell-permeable peptide inhibitors of cancer stem cell-relevant signalling pathways
Joerg Vollmer, CEO, Nexigen GmbH
16:00
Advances in oral peptide delivery
David Brayden, Professor of advanced drug delivery, University College Dublin
16:40
Chairman’s Closing Remarks and Close of Day Two
Alexandra Matzke-Ogi, CSO, Amcure

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report